Home - Products - Cell Cycle/DNA Damage - c-Myc - KJ-Pyr-9

KJ-Pyr-9

CAS No. 581073-80-5

KJ-Pyr-9( KJ Pyr9 )

Catalog No. M15131 CAS No. 581073-80-5

KJ-Pyr-9 is a novel small-molecule inhibitor of c-Myc (Kd=6.5 ± 1.0 nM).

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	54	In Stock
2MG	31	In Stock
5MG	49	In Stock
10MG	70	In Stock
25MG	141	In Stock
50MG	272	In Stock
100MG	498	In Stock
200MG	669	In Stock
500MG	1042	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

KJ-Pyr-9
Note

Research use only, not for human use.
Brief Description

KJ-Pyr-9 is a novel small-molecule inhibitor of c-Myc (Kd=6.5 ± 1.0 nM).
Description

KJ-Pyr-9 is a novel small-molecule inhibitor of c-Myc (Kd=6.5 ± 1.0 nM); interferes with MYC-MAX complex formation and inhibits MYC-induced oncogenic transformation in cells; active in xenograft mice.
In Vitro

——
In Vivo

——
Synonyms

KJ Pyr9
Pathway

Cell Cycle/DNA Damage
Target

c-Myc
Recptor

c-Myc
Research Area

Cancer
Indication

——

Chemical Information

CAS Number

581073-80-5
Formula Weight

385.3722
Molecular Formula

C22H15N3O4
Purity

>98% (HPLC)
Solubility

10 mM in DMSO
SMILES

O=C(N)C1=CC=C(C2=CC(C3=CC=CO3)=NC(C4=CC=C([N+]([O-])=O)C=C4)=C2)C=C1
Chemical Name

Benzamide, 4-[2-(2-furanyl)-6-(4-nitrophenyl)-4-pyridinyl]-

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Hart JR, et al. Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12556-61. 2. Raffeiner P, et al. Oncotarget. 2014 Oct 15;5(19):8869-78.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Nicotinamide-N-oxide

Nicotinamide N - oxide is niacin related compounds, used in the study of nicotinic acid related granulocyte differentiation mechanism.
MYCi361

MYCi361 is an inhibitor of MYC (binding to MYC with Kd of 3.2 μM). MYCi361 is a small-molecule MYC inhibitors that inhibits the viability of MYC-dependent cancer cells including prostate cancer (MycCaP, LNCaP, and PC3), leukemia (MV4-11), lymphoma (HL-60 and P493-6), and neuroblastoma (SK-N-B2) with low-micromolar IC50 values.
BET bromodomain inhi...

CPI-0610 is a potent, selective, and cell-active BET bromodomain inhibitor CPI-0610 inhibits BRD4-BD1 with IC50 of 39 nM in time-resolved fluorescence energy transfer (TR-FRET ) binding assay.

Sign In Join Free